FDA Urges Creation of Generic Abuse-Deterrent Opioid Painkillers

FDA Urges Creation of Generic Abuse-Deterrent Opioid Painkillers

The Food and Drug Administration (FDA) is urging makers of generic drugs to redesign opioid painkillers to make them abuse-deterrent, according to HealthDay.

Medications with abuse-deterrent properties are more difficult to crush or dissolve, making them harder to snort or inject.

If a medication has abuse-deterrent properties, “it does not mean the product is impossible to abuse or that these properties necessarily prevent addiction, overdose or death – notably, the FDA has not approved an opioid product with properties that are expected to deter abuse if the product is swallowed whole,” the agency said in a statement.

“By issuing the draft guidance, the FDA is helping to ensure that generic abuse-deterrent opioids are no less abuse deterrent than their brand-name counterparts,” FDA Commissioner Dr. Robert Califf said. “We hope that the availability of less costly generic products with abuse-deterrent properties has the potential to accelerate the shift away from the older products that do not include abuse-deterrent properties.”

The FDA will also require makers of brand-name opioid painkillers with abuse-deterrent labeling to conduct long-term studies on the effectiveness of the formulas in reducing abuse.

Last week the FDA announced it is requiring immediate-release opioid painkillers to carry a “black box” warning about the risk of misuse, abuse, addiction, overdose and death.

Immediate-release opioids are usually intended for use every four to six hours, while extended-release opioids are generally intended to be taken once or twice a day. According to the FDA, 90 percent of opioid prescriptions are for immediate-release opioids. The FDA placed black-box warnings on extended-release opioids in 2013.
Bottles for immediate-release opioids will have a notification stating there is a black-box warning for the drug. Patients will need to go to the manufacturer’s website for details, the article notes.

Pharmacists will be encouraged to give patients a medication guide explaining the risks of the drug.

Related Posts


Facing Addiction and The National Council on Alcoholism and Drug Dependence (NCADD) are proud to announce the merger of our organizations – creating a national leader in turning the tide on the addiction epidemic.
The merged organization will be called:

logo v2

Learn More